Global Inflation Device Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Global Inflation Device Market Segmentation, By Type (Analog Inflation Device and Digital Inflation Device), Capacity (20ml Inflation Device, 25ml Inflation Device, 30ml Inflation Device, and 60ml Inflation Device), Application (Interventional Cardiology, Peripheral Vascular Procedures, Interventional Radiology, Urological Procedures, Gastroenterological Procedures, and Others), Pressure (30 atm, 40 atm, 55 atm, and Others), Function (Stent Deployment and Fluid Delivery), End User (Hospitals, Interventional Laboratories, and Clinics), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributors) - Industry Trends and Forecast to 2032

 Inflation Device Market Size

• The global inflation device market was valued at USD 862.07 million in 2024 and is expected to reach USD 1,264.48 million by 2032, at a CAGR of 4.9% during the forecast period
• This growth is driven by factors such as wide range of applications of inflation devices, increasing number of minimally invasive surgeries and aging population and chronic disease burden

Inflation Device Market Analysis

• Inflation devices are essential tools used in various medical procedures, including angioplasty, stent placement, and other minimally invasive surgeries, enabling precise control of pressure and inflation of medical balloons
• The demand for these devices is significantly driven by the increasing prevalence of cardiovascular diseases, growing adoption of minimally invasive procedures, and technological advancements in interventional tools
• North America is expected to dominate the inflation device market due to its advanced healthcare infrastructure, high procedural volumes, and strong presence of key market players
• Asia-Pacific is expected to be the fastest growing region in the inflation device market during the forecast period due to rising healthcare expenditure, growing awareness about interventional procedures, and increasing incidence of chronic diseases
• Analog inflation device segment is expected to dominate the market with a market share of 66.65% due to its cost-effectiveness, ease of use, wide availability, and strong preference among healthcare providers for reliable and straightforward devices in routine interventional procedures, especially in emerging and resource-constrained settings

Report Scope and Inflation Device Market Segmentation     

Inflation Device Market Trends

“Integration of Precision Medicine, Minimally Invasive Techniques, and Smart Surgical Tools”

• One prominent trend in the global inflation device market is the increasing integration of precision medicine and minimally invasive surgical techniques, particularly in cardiovascular, urological, and gastrointestinal procedures
• Technological advancements such as pressure-controlled inflation systems, digital display units, and automated inflation mechanisms are transforming device accuracy, safety, and usability in complex interventions

• For instance, next-generation inflation devices with real-time pressure monitoring and smart feedback loops are enhancing procedural efficiency and reducing complications during angioplasty and stent placements

• In line with growing demand for patient-specific treatment, devices are being designed with ergonomics, intuitive interfaces, and compatibility across a range of interventional tools and catheter types
• The push for cleaner, smarter, and more sustainable surgical environments is also influencing innovation, with manufacturers focusing on compact, disposable, and environmentally friendly inflation systems
• These innovations are not only enhancing clinical outcomes and physician control but are also driving the global adoption of advanced inflation devices in both high-volume hospitals and emerging outpatient care settings

Inflation Device Market Dynamics

Driver

“Rising Case of Cardiovascular Diseases”

• Cardiovascular disease is the most common disease in people around the world. The conditions mainly comprise heart-related diseases, which occur due to blockage in the arteries
• The blockage consists of plaque, which causes narrowing of the artery and thus prevents the blood from reaching the heart
• There is a significant rise in the number of cardiovascular diseases that occur from smoking, diabetes, high blood pressure (hypertension) etc. Further, many health authorities have highlighted the issue of the huge rise in the population that is being affected by cardiovascular diseases

For instance,

• In September 2023, as per World Health Organization projected that 1.13 billion people are affected by hypertension around the world. High blood pressure contributes to heart disease, stroke, and kidney failure. Addressing hypertension through early detection, treatment, and lifestyle changes is critical to managing the increasing cardiovascular disease burden worldwide
• In November 2023, an article by NCBI highlighted the increasing prevalence of Cardiovascular Diseases (CVDs) and the need for effective interventions. As CVDs rise, the demand for procedures like angioplasty and stent placement increases, driving the need for advanced inflation devices. These devices are essential for precise balloon inflation during such procedures, ensuring optimal outcomes. Therefore, the growing focus on managing CVDs is expected to significantly boost the global inflation devices market

• The rising prevalence of cardiovascular diseases, driven by factors such as smoking, diabetes, and hypertension, poses a significant global health challenge. As the affected population continues to grow, health authorities must prioritize prevention, early detection, and effective management to curb the escalating burden

Opportunity

“Expanding Access to Interventional Care in Emerging Markets”

• Emerging markets such as India, Brazil, China, and ASEAN countries are witnessing rapid growth in healthcare spending and infrastructure development
• As these regions invest in expanding access to cardiac and interventional care, the demand for affordable medical devices is surging. Inflation devices, especially low-cost and mid-range manual pressure systems, are in high demand for routine procedures such as angioplasty in cost-sensitive healthcare settings
• The combination of rising disease burden and expanding healthcare accessibility fuels widespread adoption of these devices. This surge in demand across emerging markets acts as a strong driver for the global inflation device market, boosting both volume sales and geographic reach

For instance,

• In June 2023, as per the information published by China Briefing, China’s rapidly expanding healthcare sector, supported by rising incomes, increased health awareness, and an aging population, is a key focus area for government reform and investment. With growing demand for advanced interventional procedures, there is strong potential for innovative and affordable medical devices. This environment presents a significant opportunity for the inflation device market to expand its presence and adoption
• In April 2025, according to the article published by the Economic Times, India’s healthcare expenditure is projected to rise from 3.3% to 5% of its GDP by 2030, signaling a major shift toward enhanced healthcare access and infrastructure. This increase supports broader adoption of interventional procedures, including angioplasty. The growing investment presents a valuable opportunity for the market to expand in one of the world’s most dynamic emerging economies

• Emerging markets are rapidly improving access to interventional care, leading to increased demand for affordable medical devices. Low-cost inflation devices are especially sought after for routine procedures in cost-sensitive settings. This growing need, driven by rising disease burden and better care access, presents strong growth potential for the global inflation device market

Restraint/Challenge

“Low-Cost Alternatives of Inflation Devices”

• The emergence of low-cost alternatives to conventional inflation devices poses a significant challenge for the global inflation device market
• In resource-constrained settings, healthcare providers increasingly adopt solutions such as manual syringe-based systems, which utilize high-volume syringes to inflate balloons without the need for expensive equipment
• These systems offer basic functionality at minimal cost, making them especially appealing in developing regions. Alongside this, three-way stopcock assemblies and locally assembled kits using standard medical components further drive the shift away from high-cost devices
• The availability of refurbished and reusable inflation devices also contributes to reduced reliance on premium, single-use options. The growing preference for these affordable alternatives directly impacts the demand for conventional inflation devices, creating pricing pressures and limiting growth opportunities for established market players

For instance,

• In May 2024, as mentioned in the article published by ScienceDirect, an example of a low-cost alternative involves using a 60-mL syringe with a 3-way stopcock for rapid manual inflation and deflation of 40–50 mL of air through helium extender tubing. This simple setup delivers essential functionality without the expense of commercial devices, reducing dependence on high-cost solutions and presenting a direct challenge to the inflation device market
• In January 2020, as per the article published by NCBI, a cost-effective method involves connecting a PCI balloon to an inflation syringe using a three-way valve, which allows efficient balloon inflation while facilitating air removal. This technique ensures functional performance using standard, low-cost components. By minimizing the need for specialized inflation devices, such practices undermine the demand for premium systems and pose a growing challenge to the inflation device market

• As healthcare systems continue to prioritize cost-efficiency, especially in emerging markets, the widespread use of such alternatives is expected to intensify. This trend poses a sustained competitive threat to established players in the global inflation device market, challenging their market share and profitability

Inflation Device Market Scope

The market is segmented on the basis of type, capacity, application, pressure, function, end user, and distribution channel.

In 2025, the analog inflation device segment is projected to dominate the market with a largest share in type segment

The analog inflation device segment is expected to dominate the inflation device market with a market share of 66.65% due to its cost-effectiveness, ease of use, wide availability, and strong preference among healthcare providers for reliable and straightforward devices in routine interventional procedures, especially in emerging and resource-constrained settings.

The interventional cardiology is expected to account for the largest share during the forecast period in application segment

In 2025, the interventional cardiology segment is expected to dominate the market with the largest market share of 26.93% due to the rising prevalence of cardiovascular diseases, growing adoption of minimally invasive procedures, and increased demand for balloon angioplasty and stent placements. Technological advancements in inflation devices that enhance precision and safety further support the segment's leading position.

Inflation Device Market Regional Analysis

“North America Holds the Largest Share in the Inflation Device Market”

• North America leads the global inflation device market, driven by its advanced healthcare infrastructure, strong presence of leading medical device manufacturers, and widespread adoption of minimally invasive surgical procedures
• The U.S. holds a significant market share due to the high volume of interventional procedures, rapid integration of advanced pressure-controlled devices, and increasing demand for precision-based surgical tools
• Robust R&D investments in catheter-based therapies, along with favorable reimbursement policies, regulatory support, and access to cutting-edge manufacturing technologies, are reinforcing regional dominance
• In addition, growing focus on patient safety, increasing preference for single-use sterile devices, and the availability of technologically advanced inflation systems are further accelerating market growth across North America

“Asia-Pacific is Projected to Register the Highest CAGR in the Inflation Device Market”

• The Asia-Pacific region is expected to witness the fastest growth in the global inflation device market, driven by increasing healthcare investments, expanding hospital infrastructure, and a rising focus on minimally invasive procedures
• Countries such as China, India, Japan, and South Korea are emerging as key growth hubs due to growing surgical volumes, improved access to healthcare, and increasing adoption of advanced interventional devices
• Japan leads in innovation and precision healthcare, contributing to early adoption of high-performance inflation systems in vascular and cardiac interventions
• In China and India, rapid urbanization, growing medical tourism, and strong government support for modernizing healthcare facilities are fueling demand for inflation devices across diagnostic and therapeutic procedures
• In addition, the rise of local manufacturing, favorable regulatory reforms, and the increasing presence of global medtech companies are accelerating the region’s growth trajectory in the inflation device market

Inflation Device Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Boston Scientific Corporation (U.S.)
• BD (U.S.)
• B. Braun Interventional Systems Inc (U.S.)
• Olympus Corporation (Japan)
• Merit Medical Systems (U.S.)
• Medtronic (U.S.)
• Teleflex Incorporated (U.S.)
• CONMED Corporation (U.S.)
• Integra LifeSciences Corporation (U.S.)
• Vygon SAS (France)
• Atrion Medical (U.S.)
• Spectrum Medtech Pvt. Ltd (India)
• Medorah Meditek Pvt. Ltd. (India)
• SMT (India)
• SURETECH MEDICAL INC. (India)
• Cook (U.S.)
• Elite Medtek(Jiangsu) Co., Ltd (China)
• Advin Health Care (India)
• US Endovascular, LLC. (U.S.)
• ADVANCED LIFESCIENCES PVT. LTD. (India)

Latest Developments in Inflation Device Market

• In January 2025, Olympus Latin America acquired Sur Medical SpA’s distribution business in Chile, establishing Olympus Corporation Chile. This acquisition enables direct access to Chile’s growing healthcare market, streamlining the distribution of Olympus products and enhancing customer service and support in the region
• In November 2024, Merit Medical Systems has completed the acquisition of Cook Medical’s lead management portfolio for approximately USD 210 million. This acquisition enhances Merit’s electrophysiology and cardiac rhythm management business by adding a comprehensive range of devices used in lead removal and replacement procedures for pacemakers and implantable cardioverter-defibrillators. The integration of these products strengthens Merit’s position in the inflation device market
• In May 2024, Merit Medical Systems announced the U.S. commercial release of the basixSKY inflation device. This analog device is designed for endovascular interventions like balloon angioplasty and stent placement. It features a comfort-grip handle for one-handed preparation and minimizes rotational torque and handle revolutions to reach pressure. The device is available as a standalone solution and in kits with Merit Angioplasty Packs, configured to offer complementing AccessPLUS, Honor, and PhD hemostasis valves
• In January 2022, Medtronic has acquired Affera, a cardiac technology company specializing in mapping, navigation, and ablation systems for treating arrhythmias like atrial fibrillation. The acquisition marks Medtronic's entry into the cardiac mapping segment, expanding its cardiac ablation portfolio
• In April 2024, Integra LifeSciences Corporation has completed the acquisition of Acclarent, Inc., a company specializing in ENT (ear, nose, and throat) solutions. This acquisition enhances Integra's portfolio in the ENT market, expanding its capabilities in innovative medical technologies for sinus, ear, and nasal treatments, driving further growth in the healthcare sector 

SKU-41406